Cite
APA Citation
Komaki, Y., Komaki, F., Yamada, A., Micic, D., Ido, A., & Sakuraba, A. (2018). meta‐Analysis of the Risk of Immune‐Related Adverse Events With Anticytotoxic T‐Lymphocyte‐Associated Antigen 4 and Antiprogrammed Death 1 Therapies. Clinical pharmacology & therapeutics, 103(2), 318–331. http://access.bl.uk/ark:/81055/vdc_100055540179.0x00005b